FMR1 and fragile X syndrome: Guidelines have raised concern that universally offering FXS carrier screening will result in the need to counsel large numbers of patients about the complex inheritance patterns and range of phenotypes of FXS and FMR1 premutation carriers during an era in which the genetic counseling workforce may be experiencing a shortage (Hoskovec et al., 2018; Sherman et al., 2005).